Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials
Conditions
- Solid Tumor
- Hematological Malignancies
Interventions
- DRUG: Belinostat
- DRUG: Atazanavir
Sponsor
Acrotech Biopharma Inc.
Collaborators